Related Experiment Videos
Propofol anticonvulsant activity in experimental epileptic status
P L De Riu1, V Petruzzi, C Testa
1Department of Neurological Rehabilitation, University of Turin, Italy.
British Journal of Anaesthesia
|August 1, 1992
Summary
High doses of propofol demonstrated anticonvulsant properties in experimental status epilepticus models. Propofol effectively suppressed seizures, suggesting its potential utility when other treatments fail.
Area of Science:
- Neuroscience
- Pharmacology
- Anesthesiology
Background:
- Status epilepticus is a medical emergency characterized by prolonged seizures.
- Current treatments for status epilepticus include benzodiazepines, barbiturates, and phenytoin.
- Investigating novel anticonvulsant agents is crucial for refractory cases.
Purpose of the Study:
- To evaluate the anticonvulsant efficacy of propofol in high doses.
- To assess propofol's effects in two distinct experimental models of status epilepticus.
- To explore propofol's potential as an alternative treatment for status epilepticus.
Main Methods:
- Two experimental models were used: pentylenetetrazol (PTZ)-induced generalized seizures and penicillin G-induced focal seizures.
- Propofol was administered via single bolus injection or bolus followed by a 1-hour infusion.
- Electrical and clinical seizure activity was monitored.
Main Results:
- A single bolus of propofol (12 mg/kg) suppressed PTZ-induced seizures.
- Continuous infusion (50 mg/kg/h) prevented seizure recurrence in PTZ models.
- In focal seizures, propofol temporarily halted paroxysmal activity and reduced associated jerks, with improved suppression during infusion.
Conclusions:
- Propofol exhibits significant anticonvulsant properties in experimental status epilepticus.
- Its mechanism may involve decreasing neural membrane conductance, counteracting PTZ's effect.
- Propofol is a potential therapeutic option for status epilepticus refractory to standard treatments.